Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03856346
Other study ID # Phaco-vity-biometry study
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 1, 2019
Est. completion date September 30, 2020

Study information

Verified date April 2019
Source Cantonal Hospital of St. Gallen
Contact Josef Guber, MD
Phone +41 71 494 17 54
Email josef.guber@hotmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the study is to evaluate the degree of refractive error postoperatively in combined procedures and to calculate a new constant in order to improve current state of the art biometry calculations.


Description:

The IOL power calculation in combined phaco-vitrectomy has been performed similar to that in cataract surgery alone. In patients who undergo combined phaco-vitrectomy, deviations in refractive outcomes may be observed because of possible errors in measurement of axial length, changes in the properties of the vitreous cavity after removal of the vitreous, or intraocular tamponade. Most of the previous studies have reported variable degrees of myopic shift after phaco-vitrectomy for diabetic retinopathy, epiretinal membrane, and macular hole. Furthermore, use of intraoperative gas may increase further the risk of anterior displacement of the intraocular lens which may induce a higher myopic shift. However, these publications did not provide any quantification of the spherical deviations nor calculate any specific constant in order to improve currents state of art biometry calculations.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date September 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- Patients who undergo a combined procedure with phacoemulsification and pars plana vitrectomy

Exclusion Criteria:

- Sulcus fixation of the IOL, sulcus suture of the IOL, or intra-scleral IOL fixation because of intraoperative posterior capsule rupture

- corneal disease, such as keratoconus, that interfered with refractive results

- IOL implantation with a toric IOL or multifocal IOL

- History of previous vitrectomy or corneal transplantation

- Other coexisting ocular disease such as proliferative diabetic retinopathy, advanced age-related macular degeneration, uveitis, acute retinal necrosis, Coat's disease, proliferative vitreous retinopathy, or trauma

- Intraocular tamponade using silicon oil

Study Design


Intervention

Diagnostic Test:
Biometry
Biometry for phaco-vitrectomy procedures pre- and postoperatively

Locations

Country Name City State
Switzerland Cantonal Hospital of Sankt Gallen Sankt Gallen

Sponsors (1)

Lead Sponsor Collaborator
Cantonal Hospital of St. Gallen

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Refractive prediction error (measured by subjective refraction, in diopters) postoperative actual subjective refraction minus preoperative planned refraction in spherical equivalence (in diopters) 6 weeks postoperatively
Primary Absolute prediction error (measured by subjective refraction, in diopters) absolute value of the difference between postoperative actual refraction and preoperative planned refraction (in diopters) 6 weeks postoperatively
Primary Changes in Axial Length (measured by biometry, in milimeters) Change of axial length postoperatively (in milimeter) 6 weeks postoperatively
Primary Changes in corneal curvature (measured by corneal topography, in diopters) change in corneal curvature (in diopters) 6 weeks postoperatively